New Research Results Take Center Stage for Lallemand Health Solutions at Vitafoods Barcelona

Mirabel, April 22, 2025 – Lallemand Health Solutions is set to unveil groundbreaking scientific results from clinical research in innovative fields such as the gut-brain-skin axis, gut-muscle axis, and cardiovascular health at Vitafoods Europe in Barcelona, Spain, from May 20-22, 2025.

New Breakthrough Studies in Healthy Aging

Camille Binachon, Marketing Group Manager responsible for the healthy aging portfolio at Lallemand Health Solutions, teases: “We are launching Cerenity™, a powerful blend of three flagship probiotic strains designed to modulate the gut-muscle axis for healthy aging from within. In a new clinical trial, Cerenity™, combined with a prebiotic, supports mobility, strength, and quality of life in healthy aging. I will present the details of this innovative study and its groundbreaking results during the Nutraceutical Showcase Theatre Presentation.” She adds, “Furthermore, we have new solutions revolving around cardiovascular health, expanding our healthy aging portfolio.”

New Holistic Beauty Publication with Cerebiome® for the Gut-Brain-Skin Axis

Élodie Aragon, Product Manager in charge of the skin health portfolio, complements: “We have obtained very interesting results from a proof-of-concept study where healthy volunteers taking our pioneering psychobiotic Cerebiome® exhibited first significant results on in-and-out wellbeing. Participants noted improvement on perceived stress, circadian rhythm and skin appearance. Furthermore, this ingredient has been chosen as one of the three finalists for Ingredient of the Year in the Beauty from Within category, for the 2025 NutraIngredients Awards!”

Evidence Demonstrating Benefits on Overall Wellbeing, Including Sleep

Karine Lasfargue, Product Manager for the mental health portfolio at Lallemand Health Solutions, emphasizes: “We collaborated with Dr. Morin, a renowned sleep specialist and Director of the Sleep Research Center at Université Laval in Quebec, Canada, to study the potential role of psychobiotics in sleep quality. Our research demonstrates how Cerebiome® can be beneficial in innovative fields beyond occasional stress. Cerebiome® has also been pre-selected for the Ingredient of the Year in the Mind and Mood category for the 2025 NutraIngredients Awards!”

“Scientific research is a major key driver for product development at Lallemand Health Solutions. Year after year, we are proud to document the health benefits of probiotics to bring tangible solutions to consumers,” concludes Isabelle Champié, Vice President of Sales and Marketing.

The award winners will be celebrated at the industry’s party of the year on Wednesday, May 21st, 2025, during Vitafoods. Come and meet the team in Barcelona at booth #4C26 to discuss how you can launch innovative and impactful health solutions in your market.

About Lallemand Health Solutions

With 90 years of expertise, Lallemand Health Solutions is a global leader in the probiotic industry, specializing in the development, production, and marketing of bacteria- and yeast-based probiotic supplements for human health.

Media Contact
Marilou Luneau, Communications Manager, Lallemand Health Solutions
mluneau@lallemand.com